The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of neoadjuvant NALIRIFOX followed by chemoradiation with paclitaxel and carboplatin in locally advanced gastroesophageal cancer.
 
Jennifer Wo
Honoraria - PER
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Lynx Group
 
Matthew Strickland
Consulting or Advisory Role - Bristol Myers Squibb; Sedgwick Claims Management
 
Beow Yeap
Stock and Other Ownership Interests - SISCAPA Assay Technologies (I)
Consulting or Advisory Role - Guardant Health (I)
 
Zoe Guan
No Relationships to Disclose
 
Florence Keane
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - OncLive
 
Hannah Roberts
No Relationships to Disclose
 
Christopher Morse
No Relationships to Disclose
 
Michael Lanuti
Honoraria - Emory University
Consulting or Advisory Role - Bristol-Myers Squibb; Precisa
Research Funding - NIH/NCI; Stand up to Cancer
 
John Mullen
No Relationships to Disclose
 
Uma Sachdeva
No Relationships to Disclose
 
Hugh Auchincloss
No Relationships to Disclose
 
Bailey Mendel
No Relationships to Disclose
 
Lorraine Drapek
No Relationships to Disclose
 
Jessica Meurer
No Relationships to Disclose
 
Lawrence Blaszkowsky
No Relationships to Disclose
 
jeffrey clark
Employment - UpToDate
Research Funding - Pfizer
 
Theodore Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; NextCure; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Samuel Klempner
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; BeiGene; Daiichi Sankyo/UCB Japan; Eisai; I-Mab; Merck; Novartis; SERVIER; Taiho Oncology
Research Funding - Arcus Biosciences (Inst); BeiGene (Inst); I-Mab (Inst); Leap Therapeutics (Inst); Mersana (Inst)
Other Relationship - Clinical Care Options; NCCN; Research to Practice
(OPTIONAL) Uncompensated Relationships - Debbies Dream Foundation; Hope for Stomach Cancer